» Articles » PMID: 32901320

NMR in Target Driven Drug Discovery: Why Not?

Overview
Journal J Biomol NMR
Publisher Springer
Date 2020 Sep 9
PMID 32901320
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

No matter the source of compounds, drug discovery campaigns focused directly on the target are entirely dependent on a consistent stream of reliable data that reports on how a putative ligand interacts with the protein of interest. The data will derive from many sources including enzyme assays and many types of biophysical binding assays such as TR-FRET, SPR, thermophoresis and many others. Each method has its strengths and weaknesses, but none is as information rich and broadly applicable as NMR. Here we provide a number of examples of the utility of NMR for enabling and providing ongoing support for the early pre-clinical phase of small molecule drug discovery efforts. The examples have been selected for their usefulness in a commercial setting, with full understanding of the need for speed, cost-effectiveness and ease of implementation.

Citing Articles

B NMR of the Morphological Evolution of Traditional Chinese Medicine Borax.

Li Q, Yang Y, Wang Q, Han X, Zhu J, Zhang N Molecules. 2024; 29(1).

PMID: 38202834 PMC: 10780283. DOI: 10.3390/molecules29010251.


Technologies for Direct Detection of Covalent Protein-Drug Adducts.

Mons E, Kim R, Mulder M Pharmaceuticals (Basel). 2023; 16(4).

PMID: 37111304 PMC: 10146396. DOI: 10.3390/ph16040547.


NMR Observation of Sulfhydryl Signals in SARS-CoV-2 Main Protease Aids Structural Studies.

Robertson A, Ying J, Bax A Chembiochem. 2022; 23(19):e202200471.

PMID: 35972230 PMC: 9537880. DOI: 10.1002/cbic.202200471.


Estimating the cooperativity of PROTAC-induced ternary complexes using F NMR displacement assay.

de Castro G, Ciulli A RSC Med Chem. 2021; 12(10):1765-1770.

PMID: 34778777 PMC: 8528210. DOI: 10.1039/d1md00215e.


Integrated impedance sensing of liquid sample plug flow enables automated high throughput NMR spectroscopy.

Nassar O, Jouda M, Rapp M, Mager D, Korvink J, MacKinnon N Microsyst Nanoeng. 2021; 7:30.

PMID: 34567744 PMC: 8433180. DOI: 10.1038/s41378-021-00253-2.


References
1.
Roberts . Applications of NMR in drug discovery. Drug Discov Today. 2000; 5(6):230-240. DOI: 10.1016/s1359-6446(00)01479-3. View

2.
Tjernberg A, Markova N, Griffiths W, Hallen D . DMSO-related effects in protein characterization. J Biomol Screen. 2006; 11(2):131-7. DOI: 10.1177/1087057105284218. View

3.
Skora L, Mestan J, Fabbro D, Jahnke W, Grzesiek S . NMR reveals the allosteric opening and closing of Abelson tyrosine kinase by ATP-site and myristoyl pocket inhibitors. Proc Natl Acad Sci U S A. 2013; 110(47):E4437-45. PMC: 3839726. DOI: 10.1073/pnas.1314712110. View

4.
Pritisanac I, Degiacomi M, Alderson T, Carneiro M, Ab E, Siegal G . Automatic Assignment of Methyl-NMR Spectra of Supramolecular Machines Using Graph Theory. J Am Chem Soc. 2017; 139(28):9523-9533. DOI: 10.1021/jacs.6b11358. View

5.
Heightman T, Callahan J, Chiarparin E, Coyle J, Griffiths-Jones C, Lakdawala A . Structure-Activity and Structure-Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein-Protein Interaction. J Med Chem. 2019; 62(9):4683-4702. DOI: 10.1021/acs.jmedchem.9b00279. View